Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021
出 版 商：MarketsandMarkets
出版日期：2017/03/09
頁 數：152頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
The global coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021.
Major factors contributing to the growth of the global coronary stent market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market provide significant growth opportunities in the market. However, alternative treatment methods for CAD, stringent regulations for product approval, and numerous cases of product failure and product recall may hinder the growth of this market during the forecast period.
Various companies are focusing on technological advancements to improve the coronary stents offerings. Companies like Biosensors International Ltd., Abbott Laboratories, and Boston Scientific focused on developing biodegradable and bifurcated stents to deal with concerns about thrombosis caused by long-term device implantation. For instance, in May 2014, Boston Scientific (U.S.) launched the Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Japan. Currently, the coronary stents market is witnessing a new phase of technological developments, with the launch of fully dissolving stents. In July 2016, Abbott Laboratories (U.S.) received U.S. FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the only fully dissolving stent approved for the treatment of CAD.
Asia is projected to be fastest-growing region in the coronary stent market during the forecast period. High growth in this region can be attributed to factors such as large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs in the region. Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.
Research Coverage:
This market is categorized on the basis of type, mode of delivery, material, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios of top players in the coronary stent market. The report analyzes this market by type, mode of delivery, material, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the coronary stent market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the coronary stent market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for coronary stent across regions
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the coronary stent market
Major factors contributing to the growth of the global coronary stent market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market provide significant growth opportunities in the market. However, alternative treatment methods for CAD, stringent regulations for product approval, and numerous cases of product failure and product recall may hinder the growth of this market during the forecast period.
Various companies are focusing on technological advancements to improve the coronary stents offerings. Companies like Biosensors International Ltd., Abbott Laboratories, and Boston Scientific focused on developing biodegradable and bifurcated stents to deal with concerns about thrombosis caused by long-term device implantation. For instance, in May 2014, Boston Scientific (U.S.) launched the Promus PREMIER Everolimus-eluting Platinum Chromium Coronary Stent System in Japan. Currently, the coronary stents market is witnessing a new phase of technological developments, with the launch of fully dissolving stents. In July 2016, Abbott Laboratories (U.S.) received U.S. FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the only fully dissolving stent approved for the treatment of CAD.
Asia is projected to be fastest-growing region in the coronary stent market during the forecast period. High growth in this region can be attributed to factors such as large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs in the region. Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.
Research Coverage:
This market is categorized on the basis of type, mode of delivery, material, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios of top players in the coronary stent market. The report analyzes this market by type, mode of delivery, material, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the coronary stent market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the coronary stent market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for coronary stent across regions
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the coronary stent market
TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 KEY INDUSTRY INSIGHTS 26
2.4 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 CORONARY STENTS: MARKET OVERVIEW 31
4.2 CORONARY STENTS MARKET, BY TYPE 31
4.3 CORONARY STENTS MARKET, BY MODE OF DELIVERY (2016 VS. 2021) 32
4.4 CORONARY STENTS MARKET, BY MATERIAL (2016 VS. 2021) 32
4.5 METALLIC CORONARY STENTS MARKET, BY TYPE (2016) 33
4.6 CORONARY STENTS MARKET, BY END USER 33
4.7 GEOGRAPHIC SNAPSHOT: CORONARY STENTS MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Technological advancements 37
5.2.1.2 Rising incidence of coronary artery disease and subsequent growth in the number of PCI procedures 37
5.2.1.3 Increasing demand for minimally invasive procedures 37
5.2.1.4 Rising geriatric population 38
5.2.2 RESTRAINTS 39
5.2.2.1 Availability of alternative treatment methods for coronary artery disease 39
5.2.2.2 Stringent regulations for product approval 39
5.2.2.3 Product failure and product recalls 39
5.2.3 OPPORTUNITIES 40
5.2.3.1 Bioresorbable vascular scaffolds 40
5.2.3.2 Emerging markets 40
5.2.4 CHALLENGES 41
5.2.4.1 Complications associated with implantation of stents 41
5.2.4.2 Declining costs of stents 41
5.3 REGULATORY LANDSCAPE 41
5.4 PIPELINE PRODUCTS 42
5.5 PRICING ANALYSIS 43
6 CORONARY STENTS MARKET, BY TYPE 45
6.1 INTRODUCTION 46
6.2 BARE-METAL STENTS 47
6.3 DRUG-ELUTING STENTS 48
6.4 BIOABSORBABLE STENTS 51
7 CORONARY STENTS MARKET, BY MODE OF DELIVERY 53
7.1 INTRODUCTION 54
7.2 BALLOON-EXPANDABLE STENTS 55
7.3 SELF-EXPANDING STENTS 57
8 CORONARY STENTS MARKET, BY MATERIAL 59
8.1 INTRODUCTION 60
8.2 METALLIC STENTS 61
8.2.1 COBALT CHROMIUM 63
8.2.2 PLATINUM CHROMIUM 64
8.2.3 NICKEL TITANIUM 64
8.2.4 STAINLESS STEEL 65
8.3 OTHER STENTS 66
9 CORONARY STENTS MARKET, BY END USER 69
9.1 INTRODUCTION 70
9.2 HOSPITALS 71
9.3 CARDIAC CENTERS 73
9.4 AMBULATORY SURGICAL CENTERS 74
?
10 CORONARY STENTS MARKET, BY REGION 76
10.1 INTRODUCTION 77
10.2 NORTH AMERICA 79
10.2.1 U.S. 82
10.2.2 CANADA 84
10.3 EUROPE 86
10.3.1 GERMANY 89
10.3.2 FRANCE 91
10.3.3 U.K. 93
10.3.4 REST OF EUROPE 95
10.4 ASIA 97
10.5 REST OF THE WORLD (ROW) 101
11 COMPETITIVE LANDSCAPE 104
11.1 OVERVIEW 104
11.2 MARKET SHARE ANALYSIS 107
11.3 COMPETITIVE SITUATION AND TRENDS 108
11.3.1 APPROVALS, PRODUCT LAUNCHES, AND ENHANCEMENTS 109
11.3.2 AGREEMENTS, COLLABORATIONS, AND CONTRACTS 110
11.3.3 EXPANSIONS 111
11.3.4 ACQUISITIONS 112
12 COMPANY PROFILES 113
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 113
12.2 MEDTRONIC PLC 114
12.3 ABBOTT LABORATORIES 117
12.4 BOSTON SCIENTIFIC CORPORATION 120
12.5 BIOSENSORS INTERNATIONAL GROUP, LTD. 123
12.6 BIOTRONIK SE & CO. KG 125
12.7 B. BRAUN MELSUNGEN AG 126
12.8 TERUMO CORPORATION 128
12.9 STENTYS SA 131
12.10 MICROPORT SCIENTIFIC CORPORATION 133
12.11 MERIL LIFE SCIENCES PVT. LTD. 135
12.12 VASCULAR CONCEPTS LIMITED 136
12.13 TRANSLUMINA GMBH 137
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 138
13.1 INSIGHTS FROM INDUSTRY EXPERTS 138
13.2 DISCUSSION GUIDE 139
13.3 OTHER DEVELOPMENTS 143
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 146
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 148
13.6 AVAILABLE CUSTOMIZATIONS 149
13.7 RELATED REPORTS 150
13.8 AUTHOR DETAILS 151
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 KEY INDUSTRY INSIGHTS 26
2.4 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 CORONARY STENTS: MARKET OVERVIEW 31
4.2 CORONARY STENTS MARKET, BY TYPE 31
4.3 CORONARY STENTS MARKET, BY MODE OF DELIVERY (2016 VS. 2021) 32
4.4 CORONARY STENTS MARKET, BY MATERIAL (2016 VS. 2021) 32
4.5 METALLIC CORONARY STENTS MARKET, BY TYPE (2016) 33
4.6 CORONARY STENTS MARKET, BY END USER 33
4.7 GEOGRAPHIC SNAPSHOT: CORONARY STENTS MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 DRIVERS 37
5.2.1.1 Technological advancements 37
5.2.1.2 Rising incidence of coronary artery disease and subsequent growth in the number of PCI procedures 37
5.2.1.3 Increasing demand for minimally invasive procedures 37
5.2.1.4 Rising geriatric population 38
5.2.2 RESTRAINTS 39
5.2.2.1 Availability of alternative treatment methods for coronary artery disease 39
5.2.2.2 Stringent regulations for product approval 39
5.2.2.3 Product failure and product recalls 39
5.2.3 OPPORTUNITIES 40
5.2.3.1 Bioresorbable vascular scaffolds 40
5.2.3.2 Emerging markets 40
5.2.4 CHALLENGES 41
5.2.4.1 Complications associated with implantation of stents 41
5.2.4.2 Declining costs of stents 41
5.3 REGULATORY LANDSCAPE 41
5.4 PIPELINE PRODUCTS 42
5.5 PRICING ANALYSIS 43
6 CORONARY STENTS MARKET, BY TYPE 45
6.1 INTRODUCTION 46
6.2 BARE-METAL STENTS 47
6.3 DRUG-ELUTING STENTS 48
6.4 BIOABSORBABLE STENTS 51
7 CORONARY STENTS MARKET, BY MODE OF DELIVERY 53
7.1 INTRODUCTION 54
7.2 BALLOON-EXPANDABLE STENTS 55
7.3 SELF-EXPANDING STENTS 57
8 CORONARY STENTS MARKET, BY MATERIAL 59
8.1 INTRODUCTION 60
8.2 METALLIC STENTS 61
8.2.1 COBALT CHROMIUM 63
8.2.2 PLATINUM CHROMIUM 64
8.2.3 NICKEL TITANIUM 64
8.2.4 STAINLESS STEEL 65
8.3 OTHER STENTS 66
9 CORONARY STENTS MARKET, BY END USER 69
9.1 INTRODUCTION 70
9.2 HOSPITALS 71
9.3 CARDIAC CENTERS 73
9.4 AMBULATORY SURGICAL CENTERS 74
?
10 CORONARY STENTS MARKET, BY REGION 76
10.1 INTRODUCTION 77
10.2 NORTH AMERICA 79
10.2.1 U.S. 82
10.2.2 CANADA 84
10.3 EUROPE 86
10.3.1 GERMANY 89
10.3.2 FRANCE 91
10.3.3 U.K. 93
10.3.4 REST OF EUROPE 95
10.4 ASIA 97
10.5 REST OF THE WORLD (ROW) 101
11 COMPETITIVE LANDSCAPE 104
11.1 OVERVIEW 104
11.2 MARKET SHARE ANALYSIS 107
11.3 COMPETITIVE SITUATION AND TRENDS 108
11.3.1 APPROVALS, PRODUCT LAUNCHES, AND ENHANCEMENTS 109
11.3.2 AGREEMENTS, COLLABORATIONS, AND CONTRACTS 110
11.3.3 EXPANSIONS 111
11.3.4 ACQUISITIONS 112
12 COMPANY PROFILES 113
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 113
12.2 MEDTRONIC PLC 114
12.3 ABBOTT LABORATORIES 117
12.4 BOSTON SCIENTIFIC CORPORATION 120
12.5 BIOSENSORS INTERNATIONAL GROUP, LTD. 123
12.6 BIOTRONIK SE & CO. KG 125
12.7 B. BRAUN MELSUNGEN AG 126
12.8 TERUMO CORPORATION 128
12.9 STENTYS SA 131
12.10 MICROPORT SCIENTIFIC CORPORATION 133
12.11 MERIL LIFE SCIENCES PVT. LTD. 135
12.12 VASCULAR CONCEPTS LIMITED 136
12.13 TRANSLUMINA GMBH 137
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 138
13.1 INSIGHTS FROM INDUSTRY EXPERTS 138
13.2 DISCUSSION GUIDE 139
13.3 OTHER DEVELOPMENTS 143
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 146
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 148
13.6 AVAILABLE CUSTOMIZATIONS 149
13.7 RELATED REPORTS 150
13.8 AUTHOR DETAILS 151
